Search Results

There are 507171 results for: content related to: Intracerebral haemorrhage under interferon-β therapy

  1. Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 32–44, OH Kantarci, I Pirko and M Rodriguez

    Version of Record online : 19 DEC 2013, DOI: 10.1038/clpt.2013.196

  2. You have free access to this content
    Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 7, July 2000, Pages: 929–935, Andrade, García-Escaño, Valdivielso, Alcántara, Sánchez-Chaparro and González-Santos

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00792.x

  3. You have free access to this content
    Induction and maintenance of clinical remission by interferon-β in patients with steroid-refractory active ulcerative colitis—an open long-term pilot trial

    Alimentary Pharmacology & Therapeutics

    Volume 16, Issue 7, July 2002, Pages: 1233–1239, E. Musch, T. Andus and M. Malek

    Version of Record online : 25 JUL 2002, DOI: 10.1046/j.1365-2036.2002.01264.x

  4. You have full text access to this Open Access content
    lnterferon-β gene therapy for cancer: Basic research to clinical application

    Cancer Science

    Volume 95, Issue 11, November 2004, Pages: 858–865, Jun Yoshida, Masaaki Mizuno and Toshihiko Wakabayashi

    Version of Record online : 19 AUG 2005, DOI: 10.1111/j.1349-7006.2004.tb02194.x

  5. Neutralizing and binding anti-interferon-β (IFN-β) antibodies. A comparison between IFN-β-1a and IFN-β-1b treatment in multiple sclerosis

    European Journal of Neurology

    Volume 7, Issue 1, January 2000, Pages: 27–34, P. Kivisäkk, G. V. Alm, S. Fredrikson and H. Link

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1468-1331.2000.00002.x

  6. You have free access to this content
    Current and future disease-modifying therapies in multiple sclerosis

    International Journal of Clinical Practice

    Volume 64, Issue 5, April 2010, Pages: 637–650, S. Y. Lim and C. S. Constantinescu

    Version of Record online : 10 MAR 2010, DOI: 10.1111/j.1742-1241.2009.02261.x

  7. Cutaneous Ulcerations Following Subcutaneous Interferon β Injection to a Patient with Multiple Sclerosis

    The Journal of Dermatology

    Volume 31, Issue 8, August 2004, Pages: 671–677, Hisashi Inafuku, Mohammed Abul Kasem Khan, Tomoko Nagata and Shigeo Nonaka

    Version of Record online : 22 JUL 2014, DOI: 10.1111/j.1346-8138.2004.tb00575.x

  8. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-β therapy in relapsing and secondary-progressive multiple sclerosis patients

    Annals of Neurology

    Volume 50, Issue 4, October 2001, Pages: 443–451, Yanina Galboiz, Sarah Shapiro, Nitza Lahat, Hannah Rawashdeh and Ariel Miller

    Version of Record online : 7 AUG 2001, DOI: 10.1002/ana.1218

  9. Multiple Sclerosis

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt081

  10. Phase 2 Trial of the Continuous IV Administration of Interferon-β in Patients With Disseminated Malignant Melanoma

    SKINmed: Dermatology for the Clinician

    Volume 5, Issue 6, November/December 2006, Pages: 271–276, Susanne Voelter-Mahlknecht, 1,2 Ulrich Mahlknecht, 3 Stephan Letzel and 1 Gerhard Fierlbeck 2

    Version of Record online : 6 FEB 2007, DOI: 10.1111/j.1540-9740.2006.05678.x

  11. Dermal fibrosis and cutaneous necrosis after recombinant interferon-β1a injection in a multiple sclerosis patient

    Journal of the European Academy of Dermatology and Venereology

    Volume 19, Issue 1, January 2005, Pages: 112–113, MG Ozden, A Erel, O Erdem and MO Oztas

    Version of Record online : 19 NOV 2004, DOI: 10.1111/j.1468-3083.2004.01086.x

  12. Current status of multiple sclerosis therapy in Germany: a national survey

    European Journal of Neurology

    Volume 6, Issue 1, January 1999, Pages: 35–38, Christoph Heesen, Sabine Hauer, Bijan Hadji-Abdolrahim, Christine Berenbeck, Carsten Buhmann, Thomas Emskotter and Department of Neurology

    Version of Record online : 13 FEB 2003, DOI: 10.1046/j.1468-1331.1999.610035.x

  13. You have free access to this content
    Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-β gene promoter

    European Journal of Biochemistry

    Volume 271, Issue 18, September 2004, Pages: 3693–3703, Hongmei Yang, Gang Ma, Charles H. Lin, Melissa Orr and Marc G. Wathelet

    Version of Record online : 24 AUG 2004, DOI: 10.1111/j.1432-1033.2004.04310.x

  14. You have free access to this content
    Usefulness of combined application of double-filtration plasmapheresis and twice-daily injections of interferon-β in hemodialysis patients with hepatitis C virus genotype 1b infection and a high viral load

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E257–E260, Mikio Zeniya, Masanori Nakano, Chisato Saeki, Keitaro Yokoyama, Toru Ishikawa, Koichi Takaguchi and Hiroki Takahashi

    Version of Record online : 17 SEP 2013, DOI: 10.1111/hepr.12207

  15. You have free access to this content
    Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism


    Volume 131, Issue 2, October 2010, Pages: 268–281, Gudrun Weiss, Simon Rasmussen, Louise Hjerrild Zeuthen, Birgit Nøhr Nielsen, Hanne Jarmer, Lene Jespersen and Hanne Frøkiær

    Version of Record online : 8 JUN 2010, DOI: 10.1111/j.1365-2567.2010.03301.x

  16. Anti-adenoviral effect of interferon-β and interferon-γ in serotypes that cause acute keratoconjunctivitis

    Clinical & Experimental Ophthalmology

    Volume 39, Issue 4, May/June 2011, Pages: 358–363, Eiichi Uchio, Hirotoshi Inoue, Aki Fuchigami and Kazuaki Kadonosono

    Version of Record online : 14 JAN 2011, DOI: 10.1111/j.1442-9071.2010.02457.x

  17. Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients

    European Journal of Neurology

    Volume 19, Issue 10, October 2012, Pages: 1311–1317, P. E. H. Jensen, F. Sellebjerg, H. B. Søndergaard and P. S. Sørensen

    Version of Record online : 5 MAY 2012, DOI: 10.1111/j.1468-1331.2012.03721.x

  18. Indexes to Volume 56: Subject index

    Annals of Neurology

    Volume 56, Issue 6, December 2004, Pages: 927–982,

    Version of Record online : 23 NOV 2004, DOI: 10.1002/ana.11256

  19. Interferon-β therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production

    Annals of Neurology

    Volume 51, Issue 2, February 2002, Pages: 165–174, Adriana A. Byrnes, Justin C. McArthur and Christopher L. Karp

    Version of Record online : 13 DEC 2001, DOI: 10.1002/ana.10084

  20. The Combination of Interferon-Beta and HMG-CoA Reductase Inhibition in Multiple Sclerosis: Enthusiasm Lost too Soon?

    CNS Neuroscience & Therapeutics

    Volume 16, Issue 6, December 2010, Pages: 362–373, Johann Sellner, Martin S. Weber, Patrick Vollmar, Heinrich P. Mattle, Bernhard Hemmer and Olaf Stüve

    Version of Record online : 9 NOV 2010, DOI: 10.1111/j.1755-5949.2010.00179.x